These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 373337)

  • 21. [Relationship between the virulence of a culture and the presence of common (non-type-specific) antigens in strains of group A streptococcus of different types].
    Akimova VV; Shuratova SG; Bukhova VP; Kolesnikova VIu; Liampert IM
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):27-32. PubMed ID: 67728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of invasive (septicemic) and non invasive strains of group A streptococci isolated during a one-year national survey in France. The Groupe d'Enquête 1995 sur les Infections Streptococciques.
    Varon E; Havlickova H; Pitman C; Sarr A; Müller-Alouf H; Coignard S; Kriz P; Bouvet A
    Adv Exp Med Biol; 1997; 418():83-5. PubMed ID: 9331605
    [No Abstract]   [Full Text] [Related]  

  • 24. The production of pyrogenic exotoxins by group A streptococci.
    Hallas G
    J Hyg (Lond); 1985 Aug; 95(1):47-57. PubMed ID: 3926872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive protection by human sera in mice against challenge with strains of group B streptococci.
    Ichiman Y; Yoshida K
    Med Microbiol Immunol; 1986; 175(6):355-62. PubMed ID: 3537652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters.
    Byrne JL; Aagaard-Tillery KM; Johnson JL; Wright LJ; Silver RM
    J Reprod Immunol; 2009 Oct; 82(1):74-83. PubMed ID: 19682751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of monoclonal antibody to streptococcal nephritis-strain associated protein].
    Takasaki H
    Nihon Ika Daigaku Zasshi; 1985 Oct; 52(5):530-6. PubMed ID: 3905843
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of M protein in phagocytosis. II. Opsonization of Streptococcus pyogenes in vitro.
    Tylewska S; Hryniewicz W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):44-7. PubMed ID: 44622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serotyping of beta hemolytic streptococci and their distribution in clinical specimens].
    Söyletir G; Ener B
    Mikrobiyol Bul; 1989 Jul; 23(3):190-6. PubMed ID: 2487459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatogenic and nephritogenic group A streptococci. Myth or reality? An opening lecture.
    Martin DR
    Adv Exp Med Biol; 1997; 418():21-7. PubMed ID: 9331590
    [No Abstract]   [Full Text] [Related]  

  • 32. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin).
    Musser JM; Kapur V; Kanjilal S; Shah U; Musher DM; Barg NL; Johnston KH; Schlievert PM; Henrichsen J; Gerlach D
    J Infect Dis; 1993 Feb; 167(2):337-46. PubMed ID: 8093623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
    Stevens DL; Tanner MH; Winship J; Swarts R; Ries KM; Schlievert PM; Kaplan E
    N Engl J Med; 1989 Jul; 321(1):1-7. PubMed ID: 2659990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of hyaluronic acid in the virulence of group A streptococci].
    Burova LA; Rits M; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):44-7. PubMed ID: 7034413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity to the group A Streptococcus may be only strain specific.
    de Malmanche SA; Martin DR
    Med Microbiol Immunol; 1994 Dec; 183(6):299-306. PubMed ID: 7596313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
    Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
    Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency invasion of mammalian cells by beta hemolytic streptococci.
    Cleary PP; Cue D
    Subcell Biochem; 2000; 33():137-66. PubMed ID: 10804855
    [No Abstract]   [Full Text] [Related]  

  • 38. [A study on streptococcal prevalence in Chiang Mai, Thailand, with special reference to unusual combination between T and M antigens of group A Streptococcus].
    Murai T; Inazumi Y; Pruksakorn S
    Kansenshogaku Zasshi; 1988 Oct; 62(10):869-77. PubMed ID: 3145307
    [No Abstract]   [Full Text] [Related]  

  • 39. [Toxic shock syndrome in infection due to Streptococcus pyogenes].
    Bombeli T; Bertel O; Vuilliomenet A
    Schweiz Med Wochenschr; 1992 Feb; 122(5):153-7. PubMed ID: 1738821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group A streptococci in the 1990s.
    Efstratiou A
    J Antimicrob Chemother; 2000 Feb; 45 Suppl():3-12. PubMed ID: 10759357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.